Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Zhijia Tang"'
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Pharmacist clinics offer professional pharmaceutical services that can improve public health outcomes. However, primary healthcare staff in China face various barriers and challenges in implementing such clinics. To identify exist
Externí odkaz:
https://doaj.org/article/ef5f9b41c9cf43188495b72c3d0355af
Autor:
Nuo Xu, Yufei Shi, Yixue Wang, Wenyao Mak, Wenyu Yang, Kar Weng Ng, Yue Wu, Zhijia Tang, Qingfeng He, Gangfeng Yan, Xiaoqiang Xiang, Xiao Zhu
Publikováno v:
Pharmaceutics, Vol 16, Iss 6, p 819 (2024)
Background: Caspofungin is an echinocandin antifungal agent commonly used as the first-line therapy for invasive candidiasis, salvage therapy for invasive aspergillosis, and empirical therapy for presumed fungal infections. Pharmacokinetic (PK) varia
Externí odkaz:
https://doaj.org/article/bf6ebeaa7c4e4fc68a5843de4c6596cb
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Individuals with diabetes have increased risk of depression, but there are limited nationally representative studies on this topic. We aimed to investigate the prevalence and predictors of depression, as well as its impact on all-
Externí odkaz:
https://doaj.org/article/d555c2bb7cb84c1bb3b31e74d034ffc2
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/ec775befcb79423dac2c3463b8f10869
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Oral semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that improves glycated hemoglobin levels and body weight in patients with type 2 diabetes (T2DM). We aim to evaluate the cost-effectiveness of once-daily oral sem
Externí odkaz:
https://doaj.org/article/7787c2d7e9d047c39923064ae218c260
Autor:
Meng Gu, Anning Li, Wenyao Mak, Fang Dong, Nuo Xu, Jingye Zhang, Yufei Shi, Nan Zheng, Zhijia Tang, Qingfeng He, Canjun Ruan, Wei Guo, Xiaoqiang Xiang, Chuanyue Wang, Bing Han, Xiao Zhu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
The sublingual combination of buprenorphine (BUP) and naloxone (NLX) is a new treatment option for opioid use disorder (OUD) and is effective in preventing drug abuse. This study aimed to explore rational dosing regimen for OUD patients in China via
Externí odkaz:
https://doaj.org/article/933daccccc2444fb91a462f11a434e0f
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: We aimed to evaluate alirocumab- and evolocumab-related adverse events (AEs) in real-world compared with all other drugs, overall and by gender and age subgroups; we also aimed to compare their risks of cognitive impairment, musculoskeleta
Externí odkaz:
https://doaj.org/article/ff044fc14c454f87be9459d9221a56bd
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Objectives To describe the development of pharmaceutical retail market and community pharmacists in mainland China and identify challenges from both government and business perspectives.Design A retrospective cross-sectional study.Setting Community p
Externí odkaz:
https://doaj.org/article/8869b857aa2948e49d2284ec7c63e2ec
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
ObjectivesTo assess the contemporary prevalence and decadal trends of depression and antidepressant use among adults with cardiovascular disease (CVD) in the United States, as well as their risk factors from 2009 to 2020.Materials and methodsWe used
Externí odkaz:
https://doaj.org/article/990b34191f1247f2bd16434b27754cb8
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Lung cancer is a type of cancer with higher morbidity and mortality. In spite of the impressive response rates of nab-paclitaxel (nab-PTX) or programmed cell death-1 (PD-1) and its ligand inhibitors, the effective treatment remains limited. Currently
Externí odkaz:
https://doaj.org/article/9f32eda2a62b40a4888b13081b51ef98